nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—CYP26A1—embryo—malignant glioma	0.0209	0.0969	CbGeAlD
Acitretin—RBP1—embryo—malignant glioma	0.0125	0.0578	CbGeAlD
Acitretin—Retinal haemorrhage—Carmustine—malignant glioma	0.0113	0.0333	CcSEcCtD
Acitretin—RBP1—retina—malignant glioma	0.0111	0.0511	CbGeAlD
Acitretin—RXRA—telencephalon—malignant glioma	0.0105	0.0484	CbGeAlD
Acitretin—RBP1—telencephalon—malignant glioma	0.0102	0.047	CbGeAlD
Acitretin—Intracranial pressure increased—Carmustine—malignant glioma	0.00885	0.026	CcSEcCtD
Acitretin—RXRB—telencephalon—malignant glioma	0.00864	0.04	CbGeAlD
Acitretin—Impaired healing—Carmustine—malignant glioma	0.00855	0.0251	CcSEcCtD
Acitretin—RARG—retina—malignant glioma	0.00834	0.0386	CbGeAlD
Acitretin—CYP26A1—brain—malignant glioma	0.00768	0.0355	CbGeAlD
Acitretin—RBP1—midbrain—malignant glioma	0.0073	0.0338	CbGeAlD
Acitretin—RXRG—medulla oblongata—malignant glioma	0.00722	0.0334	CbGeAlD
Acitretin—RARA—telencephalon—malignant glioma	0.00722	0.0334	CbGeAlD
Acitretin—RBP1—spinal cord—malignant glioma	0.00712	0.033	CbGeAlD
Acitretin—RXRG—midbrain—malignant glioma	0.0066	0.0305	CbGeAlD
Acitretin—RXRG—spinal cord—malignant glioma	0.00644	0.0298	CbGeAlD
Acitretin—Tretinoin—CYP2C18—malignant glioma	0.00623	0.574	CrCbGaD
Acitretin—Febrile neutropenia—Carmustine—malignant glioma	0.00614	0.018	CcSEcCtD
Acitretin—Haemorrhoids—Temozolomide—malignant glioma	0.00607	0.0178	CcSEcCtD
Acitretin—Visual acuity reduced—Temozolomide—malignant glioma	0.006	0.0176	CcSEcCtD
Acitretin—RXRA—central nervous system—malignant glioma	0.00595	0.0275	CbGeAlD
Acitretin—Febrile neutropenia—Temozolomide—malignant glioma	0.00594	0.0174	CcSEcCtD
Acitretin—RBP1—central nervous system—malignant glioma	0.00578	0.0267	CbGeAlD
Acitretin—RBP1—cerebellum—malignant glioma	0.00565	0.0261	CbGeAlD
Acitretin—Embolism—Temozolomide—malignant glioma	0.00556	0.0163	CcSEcCtD
Acitretin—Cyst—Carmustine—malignant glioma	0.00553	0.0162	CcSEcCtD
Acitretin—RARB—cerebellum—malignant glioma	0.00523	0.0242	CbGeAlD
Acitretin—RXRG—central nervous system—malignant glioma	0.00523	0.0242	CbGeAlD
Acitretin—Myopathy—Temozolomide—malignant glioma	0.00509	0.0149	CcSEcCtD
Acitretin—Influenza-like symptoms—Temozolomide—malignant glioma	0.005	0.0147	CcSEcCtD
Acitretin—RXRB—central nervous system—malignant glioma	0.00491	0.0227	CbGeAlD
Acitretin—Scotoma—Carmustine—malignant glioma	0.00487	0.0143	CcSEcCtD
Acitretin—RXRB—cerebellum—malignant glioma	0.0048	0.0222	CbGeAlD
Acitretin—RXRA—brain—malignant glioma	0.00473	0.0219	CbGeAlD
Acitretin—Scotoma—Temozolomide—malignant glioma	0.0047	0.0138	CcSEcCtD
Acitretin—Tretinoin—CYP2B6—malignant glioma	0.00462	0.426	CrCbGaD
Acitretin—RBP1—brain—malignant glioma	0.00459	0.0212	CbGeAlD
Acitretin—Otitis media—Temozolomide—malignant glioma	0.00459	0.0135	CcSEcCtD
Acitretin—Hyperaesthesia—Temozolomide—malignant glioma	0.00455	0.0134	CcSEcCtD
Acitretin—Rigors—Temozolomide—malignant glioma	0.00437	0.0128	CcSEcCtD
Acitretin—RARG—central nervous system—malignant glioma	0.00436	0.0202	CbGeAlD
Acitretin—RARG—cerebellum—malignant glioma	0.00426	0.0197	CbGeAlD
Acitretin—RARB—brain—malignant glioma	0.00425	0.0196	CbGeAlD
Acitretin—RXRG—brain—malignant glioma	0.00415	0.0192	CbGeAlD
Acitretin—RARA—central nervous system—malignant glioma	0.0041	0.019	CbGeAlD
Acitretin—Breast pain—Temozolomide—malignant glioma	0.00409	0.012	CcSEcCtD
Acitretin—RARA—cerebellum—malignant glioma	0.00401	0.0185	CbGeAlD
Acitretin—RXRB—brain—malignant glioma	0.0039	0.018	CbGeAlD
Acitretin—Herpes simplex—Temozolomide—malignant glioma	0.00388	0.0114	CcSEcCtD
Acitretin—Gait disturbance—Carmustine—malignant glioma	0.00379	0.0111	CcSEcCtD
Acitretin—Gait disturbance—Temozolomide—malignant glioma	0.00366	0.0107	CcSEcCtD
Acitretin—Skin exfoliation—Carmustine—malignant glioma	0.00353	0.0104	CcSEcCtD
Acitretin—Candida infection—Carmustine—malignant glioma	0.00353	0.0104	CcSEcCtD
Acitretin—Influenza like illness—Temozolomide—malignant glioma	0.00347	0.0102	CcSEcCtD
Acitretin—RARG—brain—malignant glioma	0.00346	0.016	CbGeAlD
Acitretin—Skin exfoliation—Temozolomide—malignant glioma	0.00341	0.01	CcSEcCtD
Acitretin—Candida infection—Temozolomide—malignant glioma	0.00341	0.01	CcSEcCtD
Acitretin—Dry eye—Temozolomide—malignant glioma	0.0033	0.00968	CcSEcCtD
Acitretin—RARA—brain—malignant glioma	0.00326	0.0151	CbGeAlD
Acitretin—Diabetes mellitus—Carmustine—malignant glioma	0.00308	0.00905	CcSEcCtD
Acitretin—Ear pain—Temozolomide—malignant glioma	0.00304	0.00892	CcSEcCtD
Acitretin—Eye pain—Carmustine—malignant glioma	0.00297	0.00872	CcSEcCtD
Acitretin—Gastroenteritis—Temozolomide—malignant glioma	0.00292	0.00858	CcSEcCtD
Acitretin—Vascular purpura—Temozolomide—malignant glioma	0.0029	0.0085	CcSEcCtD
Acitretin—Deafness—Temozolomide—malignant glioma	0.0029	0.0085	CcSEcCtD
Acitretin—Eye pain—Temozolomide—malignant glioma	0.00287	0.00843	CcSEcCtD
Acitretin—Hot flush—Temozolomide—malignant glioma	0.00277	0.00813	CcSEcCtD
Acitretin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00275	0.00806	CcSEcCtD
Acitretin—Menopausal symptoms—Temozolomide—malignant glioma	0.00275	0.00806	CcSEcCtD
Acitretin—Thirst—Temozolomide—malignant glioma	0.00272	0.00799	CcSEcCtD
Acitretin—Purpura—Temozolomide—malignant glioma	0.00269	0.00789	CcSEcCtD
Acitretin—Diplopia—Carmustine—malignant glioma	0.00268	0.00787	CcSEcCtD
Acitretin—Diplopia—Temozolomide—malignant glioma	0.00259	0.00761	CcSEcCtD
Acitretin—Liver function test abnormal—Carmustine—malignant glioma	0.00248	0.00727	CcSEcCtD
Acitretin—Dry skin—Temozolomide—malignant glioma	0.00238	0.00697	CcSEcCtD
Acitretin—Muscular weakness—Carmustine—malignant glioma	0.00237	0.00694	CcSEcCtD
Acitretin—Muscular weakness—Temozolomide—malignant glioma	0.00229	0.00671	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00229	0.00671	CcSEcCtD
Acitretin—Pancytopenia—Carmustine—malignant glioma	0.0022	0.00646	CcSEcCtD
Acitretin—Sweating increased—Temozolomide—malignant glioma	0.00218	0.00641	CcSEcCtD
Acitretin—Pancytopenia—Temozolomide—malignant glioma	0.00213	0.00624	CcSEcCtD
Acitretin—Dysuria—Temozolomide—malignant glioma	0.0021	0.00615	CcSEcCtD
Acitretin—Erectile dysfunction—Temozolomide—malignant glioma	0.00206	0.00606	CcSEcCtD
Acitretin—Depression—Carmustine—malignant glioma	0.00206	0.00605	CcSEcCtD
Acitretin—Photosensitivity reaction—Temozolomide—malignant glioma	0.00205	0.006	CcSEcCtD
Acitretin—Weight increased—Temozolomide—malignant glioma	0.00204	0.00598	CcSEcCtD
Acitretin—Weight decreased—Temozolomide—malignant glioma	0.00203	0.00595	CcSEcCtD
Acitretin—Neuropathy peripheral—Carmustine—malignant glioma	0.00203	0.00595	CcSEcCtD
Acitretin—Stomatitis—Carmustine—malignant glioma	0.00202	0.00591	CcSEcCtD
Acitretin—Urinary tract infection—Carmustine—malignant glioma	0.00201	0.0059	CcSEcCtD
Acitretin—Depression—Temozolomide—malignant glioma	0.00199	0.00585	CcSEcCtD
Acitretin—Neuropathy peripheral—Temozolomide—malignant glioma	0.00196	0.00575	CcSEcCtD
Acitretin—Stomatitis—Temozolomide—malignant glioma	0.00195	0.00571	CcSEcCtD
Acitretin—Urinary tract infection—Temozolomide—malignant glioma	0.00194	0.0057	CcSEcCtD
Acitretin—Sinusitis—Temozolomide—malignant glioma	0.00187	0.0055	CcSEcCtD
Acitretin—Haemoglobin—Carmustine—malignant glioma	0.00187	0.00547	CcSEcCtD
Acitretin—Haemorrhage—Carmustine—malignant glioma	0.00186	0.00545	CcSEcCtD
Acitretin—Hypoaesthesia—Carmustine—malignant glioma	0.00185	0.00542	CcSEcCtD
Acitretin—ALB—brain—malignant glioma	0.00184	0.00849	CbGeAlD
Acitretin—Oedema peripheral—Carmustine—malignant glioma	0.00183	0.00537	CcSEcCtD
Acitretin—Haemoglobin—Temozolomide—malignant glioma	0.0018	0.00529	CcSEcCtD
Acitretin—Haemorrhage—Temozolomide—malignant glioma	0.00179	0.00526	CcSEcCtD
Acitretin—Hepatitis—Temozolomide—malignant glioma	0.00179	0.00526	CcSEcCtD
Acitretin—Visual impairment—Carmustine—malignant glioma	0.00179	0.00525	CcSEcCtD
Acitretin—Hypoaesthesia—Temozolomide—malignant glioma	0.00178	0.00524	CcSEcCtD
Acitretin—Pharyngitis—Temozolomide—malignant glioma	0.00178	0.00522	CcSEcCtD
Acitretin—Oedema peripheral—Temozolomide—malignant glioma	0.00177	0.00518	CcSEcCtD
Acitretin—Eye disorder—Carmustine—malignant glioma	0.00173	0.00509	CcSEcCtD
Acitretin—Visual impairment—Temozolomide—malignant glioma	0.00173	0.00507	CcSEcCtD
Acitretin—Flushing—Carmustine—malignant glioma	0.00172	0.00505	CcSEcCtD
Acitretin—Eye disorder—Temozolomide—malignant glioma	0.00168	0.00492	CcSEcCtD
Acitretin—Tinnitus—Temozolomide—malignant glioma	0.00167	0.00491	CcSEcCtD
Acitretin—Flushing—Temozolomide—malignant glioma	0.00166	0.00488	CcSEcCtD
Acitretin—Alopecia—Carmustine—malignant glioma	0.00164	0.00481	CcSEcCtD
Acitretin—Angiopathy—Temozolomide—malignant glioma	0.00163	0.00478	CcSEcCtD
Acitretin—Immune system disorder—Temozolomide—malignant glioma	0.00162	0.00475	CcSEcCtD
Acitretin—Erythema—Carmustine—malignant glioma	0.00162	0.00474	CcSEcCtD
Acitretin—Chills—Temozolomide—malignant glioma	0.00161	0.00472	CcSEcCtD
Acitretin—Alopecia—Temozolomide—malignant glioma	0.00158	0.00465	CcSEcCtD
Acitretin—Back pain—Carmustine—malignant glioma	0.00156	0.00459	CcSEcCtD
Acitretin—Erythema—Temozolomide—malignant glioma	0.00156	0.00458	CcSEcCtD
Acitretin—Dysgeusia—Temozolomide—malignant glioma	0.00153	0.00449	CcSEcCtD
Acitretin—Vision blurred—Carmustine—malignant glioma	0.00152	0.00447	CcSEcCtD
Acitretin—Back pain—Temozolomide—malignant glioma	0.00151	0.00443	CcSEcCtD
Acitretin—Vision blurred—Temozolomide—malignant glioma	0.00147	0.00432	CcSEcCtD
Acitretin—Ill-defined disorder—Temozolomide—malignant glioma	0.00145	0.00425	CcSEcCtD
Acitretin—Angioedema—Temozolomide—malignant glioma	0.00143	0.00419	CcSEcCtD
Acitretin—Malaise—Temozolomide—malignant glioma	0.00141	0.00413	CcSEcCtD
Acitretin—Chest pain—Carmustine—malignant glioma	0.00138	0.00404	CcSEcCtD
Acitretin—Myalgia—Carmustine—malignant glioma	0.00138	0.00404	CcSEcCtD
Acitretin—Anxiety—Carmustine—malignant glioma	0.00137	0.00402	CcSEcCtD
Acitretin—Cough—Temozolomide—malignant glioma	0.00136	0.004	CcSEcCtD
Acitretin—Myalgia—Temozolomide—malignant glioma	0.00133	0.0039	CcSEcCtD
Acitretin—Arthralgia—Temozolomide—malignant glioma	0.00133	0.0039	CcSEcCtD
Acitretin—Anxiety—Temozolomide—malignant glioma	0.00132	0.00389	CcSEcCtD
Acitretin—Oedema—Carmustine—malignant glioma	0.00132	0.00387	CcSEcCtD
Acitretin—Discomfort—Temozolomide—malignant glioma	0.00131	0.00385	CcSEcCtD
Acitretin—Infection—Carmustine—malignant glioma	0.00131	0.00384	CcSEcCtD
Acitretin—Dry mouth—Temozolomide—malignant glioma	0.0013	0.00381	CcSEcCtD
Acitretin—Oedema—Temozolomide—malignant glioma	0.00127	0.00374	CcSEcCtD
Acitretin—Infection—Temozolomide—malignant glioma	0.00127	0.00371	CcSEcCtD
Acitretin—Anorexia—Carmustine—malignant glioma	0.00126	0.00369	CcSEcCtD
Acitretin—Skin disorder—Temozolomide—malignant glioma	0.00124	0.00363	CcSEcCtD
Acitretin—Hyperhidrosis—Temozolomide—malignant glioma	0.00123	0.00361	CcSEcCtD
Acitretin—Anorexia—Temozolomide—malignant glioma	0.00121	0.00356	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0012	0.00353	CcSEcCtD
Acitretin—Insomnia—Carmustine—malignant glioma	0.00119	0.0035	CcSEcCtD
Acitretin—Paraesthesia—Carmustine—malignant glioma	0.00118	0.00347	CcSEcCtD
Acitretin—Somnolence—Carmustine—malignant glioma	0.00117	0.00344	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00116	0.00341	CcSEcCtD
Acitretin—Insomnia—Temozolomide—malignant glioma	0.00115	0.00338	CcSEcCtD
Acitretin—Decreased appetite—Carmustine—malignant glioma	0.00115	0.00336	CcSEcCtD
Acitretin—Paraesthesia—Temozolomide—malignant glioma	0.00114	0.00336	CcSEcCtD
Acitretin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00114	0.00334	CcSEcCtD
Acitretin—Somnolence—Temozolomide—malignant glioma	0.00113	0.00332	CcSEcCtD
Acitretin—Pain—Carmustine—malignant glioma	0.00113	0.00331	CcSEcCtD
Acitretin—Constipation—Carmustine—malignant glioma	0.00113	0.00331	CcSEcCtD
Acitretin—Dyspepsia—Temozolomide—malignant glioma	0.00112	0.00329	CcSEcCtD
Acitretin—Decreased appetite—Temozolomide—malignant glioma	0.00111	0.00325	CcSEcCtD
Acitretin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0011	0.00323	CcSEcCtD
Acitretin—Fatigue—Temozolomide—malignant glioma	0.0011	0.00322	CcSEcCtD
Acitretin—Pain—Temozolomide—malignant glioma	0.00109	0.0032	CcSEcCtD
Acitretin—Constipation—Temozolomide—malignant glioma	0.00109	0.0032	CcSEcCtD
Acitretin—Feeling abnormal—Carmustine—malignant glioma	0.00109	0.00319	CcSEcCtD
Acitretin—Gastrointestinal pain—Carmustine—malignant glioma	0.00108	0.00316	CcSEcCtD
Acitretin—Feeling abnormal—Temozolomide—malignant glioma	0.00105	0.00308	CcSEcCtD
Acitretin—Body temperature increased—Carmustine—malignant glioma	0.00104	0.00306	CcSEcCtD
Acitretin—Abdominal pain—Carmustine—malignant glioma	0.00104	0.00306	CcSEcCtD
Acitretin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00104	0.00306	CcSEcCtD
Acitretin—Urticaria—Temozolomide—malignant glioma	0.00101	0.00297	CcSEcCtD
Acitretin—Abdominal pain—Temozolomide—malignant glioma	0.00101	0.00296	CcSEcCtD
Acitretin—Body temperature increased—Temozolomide—malignant glioma	0.00101	0.00296	CcSEcCtD
Acitretin—Hypersensitivity—Carmustine—malignant glioma	0.000971	0.00285	CcSEcCtD
Acitretin—Asthenia—Carmustine—malignant glioma	0.000946	0.00278	CcSEcCtD
Acitretin—Hypersensitivity—Temozolomide—malignant glioma	0.000939	0.00275	CcSEcCtD
Acitretin—Asthenia—Temozolomide—malignant glioma	0.000914	0.00268	CcSEcCtD
Acitretin—Diarrhoea—Carmustine—malignant glioma	0.000902	0.00265	CcSEcCtD
Acitretin—Pruritus—Temozolomide—malignant glioma	0.000901	0.00265	CcSEcCtD
Acitretin—Dizziness—Carmustine—malignant glioma	0.000872	0.00256	CcSEcCtD
Acitretin—Diarrhoea—Temozolomide—malignant glioma	0.000872	0.00256	CcSEcCtD
Acitretin—Dizziness—Temozolomide—malignant glioma	0.000843	0.00247	CcSEcCtD
Acitretin—Vomiting—Carmustine—malignant glioma	0.000838	0.00246	CcSEcCtD
Acitretin—Rash—Carmustine—malignant glioma	0.000831	0.00244	CcSEcCtD
Acitretin—Dermatitis—Carmustine—malignant glioma	0.000831	0.00244	CcSEcCtD
Acitretin—Headache—Carmustine—malignant glioma	0.000826	0.00242	CcSEcCtD
Acitretin—Vomiting—Temozolomide—malignant glioma	0.00081	0.00238	CcSEcCtD
Acitretin—Rash—Temozolomide—malignant glioma	0.000803	0.00236	CcSEcCtD
Acitretin—Dermatitis—Temozolomide—malignant glioma	0.000803	0.00236	CcSEcCtD
Acitretin—Headache—Temozolomide—malignant glioma	0.000798	0.00234	CcSEcCtD
Acitretin—Nausea—Carmustine—malignant glioma	0.000783	0.0023	CcSEcCtD
Acitretin—Nausea—Temozolomide—malignant glioma	0.000757	0.00222	CcSEcCtD
Acitretin—RARB—Gene Expression—NCOR1—malignant glioma	0.000187	0.000433	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000187	0.000432	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SPP1—malignant glioma	0.000187	0.000432	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HES1—malignant glioma	0.000184	0.000425	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NCOR1—malignant glioma	0.000183	0.000423	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—DNMT3B—malignant glioma	0.000181	0.00042	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NCOR1—malignant glioma	0.000179	0.000415	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NCOR1—malignant glioma	0.000179	0.000415	CbGpPWpGaD
Acitretin—RBP1—Disease—FGF2—malignant glioma	0.000179	0.000414	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000179	0.000414	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ANGPT2—malignant glioma	0.000178	0.000412	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—MYC—malignant glioma	0.000177	0.000409	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TERT—malignant glioma	0.000177	0.000409	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.000177	0.000409	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HIST1H3B—malignant glioma	0.000176	0.000408	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	0.000174	0.000402	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000173	0.000401	CbGpPWpGaD
Acitretin—RXRA—Metabolism—IDH2—malignant glioma	0.000173	0.0004	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PDGFB—malignant glioma	0.000173	0.000399	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FGFR1—malignant glioma	0.000172	0.000397	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HIF1A—malignant glioma	0.000169	0.000391	CbGpPWpGaD
Acitretin—RBP1—Disease—MDM2—malignant glioma	0.000168	0.000388	CbGpPWpGaD
Acitretin—RBP1—Disease—RAF1—malignant glioma	0.000167	0.000386	CbGpPWpGaD
Acitretin—RBP1—Disease—ERBB2—malignant glioma	0.000165	0.000382	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CAV1—malignant glioma	0.000164	0.000378	CbGpPWpGaD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000163	0.000378	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000163	0.000377	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CB—malignant glioma	0.000163	0.000377	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2B6—malignant glioma	0.000163	0.000376	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000162	0.000376	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—MYC—malignant glioma	0.000162	0.000374	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KDR—malignant glioma	0.000162	0.000374	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—malignant glioma	0.000162	0.000374	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00016	0.000369	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CAV1—malignant glioma	0.000159	0.000369	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—VEGFA—malignant glioma	0.000159	0.000367	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—malignant glioma	0.000159	0.000367	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TNF—malignant glioma	0.000159	0.000367	CbGpPWpGaD
Acitretin—RARG—Gene Expression—NOTCH1—malignant glioma	0.000158	0.000366	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—FGFR1—malignant glioma	0.000156	0.000362	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000156	0.000361	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FN1—malignant glioma	0.000156	0.00036	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—F2—malignant glioma	0.000156	0.00036	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HIST1H3B—malignant glioma	0.000154	0.000357	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—BAD—malignant glioma	0.000154	0.000356	CbGpPWpGaD
Acitretin—ALB—Hemostasis—MYB—malignant glioma	0.000153	0.000353	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NOTCH1—malignant glioma	0.000152	0.000353	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000152	0.000353	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—malignant glioma	0.000152	0.000352	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—malignant glioma	0.000152	0.000352	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000151	0.00035	CbGpPWpGaD
Acitretin—RARG—Gene Expression—PPARG—malignant glioma	0.000149	0.000346	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CD80—malignant glioma	0.000149	0.000345	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—APC—malignant glioma	0.000149	0.000345	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CG—malignant glioma	0.000149	0.000345	CbGpPWpGaD
Acitretin—RXRA—Metabolism—IDH1—malignant glioma	0.000149	0.000344	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000149	0.000344	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000147	0.000341	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000147	0.000341	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000147	0.000341	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGF—malignant glioma	0.000147	0.000341	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KDR—malignant glioma	0.000147	0.000341	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTPN11—malignant glioma	0.000146	0.000339	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CG—malignant glioma	0.000145	0.000336	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—NOTCH1—malignant glioma	0.000145	0.000335	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MET—malignant glioma	0.000144	0.000333	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SPHK1—malignant glioma	0.000144	0.000333	CbGpPWpGaD
Acitretin—RARB—Gene Expression—NOTCH1—malignant glioma	0.000142	0.000329	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CYP2C18—malignant glioma	0.000141	0.000326	CbGpPWpGaD
Acitretin—RBP1—Disease—PTEN—malignant glioma	0.000141	0.000326	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PPARG—malignant glioma	0.00014	0.000324	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—BRAF—malignant glioma	0.00014	0.000324	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—malignant glioma	0.00014	0.000324	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—PPARG—malignant glioma	0.000139	0.000322	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NOTCH1—malignant glioma	0.000139	0.000321	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—PPARG—malignant glioma	0.000137	0.000316	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000136	0.000316	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT2—malignant glioma	0.000136	0.000315	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—NOTCH1—malignant glioma	0.000136	0.000315	CbGpPWpGaD
Acitretin—RARA—Gene Expression—NOTCH1—malignant glioma	0.000136	0.000315	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—H3F3A—malignant glioma	0.000136	0.000315	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000136	0.000314	CbGpPWpGaD
Acitretin—RARB—Gene Expression—PPARG—malignant glioma	0.000134	0.00031	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PTPN11—malignant glioma	0.000133	0.000308	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000133	0.000308	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000131	0.000303	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CD—malignant glioma	0.000131	0.000303	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PPARG—malignant glioma	0.000131	0.000303	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PPARG—malignant glioma	0.000128	0.000297	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PPARG—malignant glioma	0.000128	0.000297	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH3—malignant glioma	0.000128	0.000296	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CD—malignant glioma	0.000128	0.000295	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—TNF—malignant glioma	0.000126	0.000292	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—malignant glioma	0.000126	0.000292	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FGF2—malignant glioma	0.000125	0.00029	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT2—malignant glioma	0.000124	0.000287	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000123	0.000285	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000123	0.000285	CbGpPWpGaD
Acitretin—ALB—Metabolism—COX8A—malignant glioma	0.000122	0.000283	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000121	0.00028	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP2—malignant glioma	0.00012	0.000278	CbGpPWpGaD
Acitretin—ALB—Hemostasis—H3F3A—malignant glioma	0.000119	0.000275	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000118	0.000272	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MDM2—malignant glioma	0.000117	0.000272	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—malignant glioma	0.000117	0.000271	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RAF1—malignant glioma	0.000117	0.000271	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000117	0.00027	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000116	0.000269	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ERBB2—malignant glioma	0.000116	0.000268	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH2—malignant glioma	0.000115	0.000265	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—malignant glioma	0.000115	0.000265	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CB—malignant glioma	0.000114	0.000264	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—FGF2—malignant glioma	0.000114	0.000264	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTT1—malignant glioma	0.000114	0.000264	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CB—malignant glioma	0.000111	0.000258	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000111	0.000256	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—malignant glioma	0.00011	0.000255	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL8—malignant glioma	0.00011	0.000254	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000109	0.000253	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—malignant glioma	0.000108	0.00025	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000108	0.000249	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS1—malignant glioma	0.000107	0.000247	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000106	0.000246	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—RAF1—malignant glioma	0.000106	0.000246	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—malignant glioma	0.000105	0.000244	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—malignant glioma	0.000105	0.000243	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—malignant glioma	0.000105	0.000243	CbGpPWpGaD
Acitretin—ALB—Metabolism—ASMT—malignant glioma	0.000104	0.000241	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000104	0.000241	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000103	0.000239	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000102	0.000235	CbGpPWpGaD
Acitretin—RBP1—Disease—PIK3CA—malignant glioma	9.94e-05	0.00023	CbGpPWpGaD
Acitretin—RXRA—Metabolism—BCHE—malignant glioma	9.94e-05	0.00023	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MMP9—malignant glioma	9.92e-05	0.00023	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTEN—malignant glioma	9.87e-05	0.000228	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—CDKN2B—malignant glioma	9.85e-05	0.000228	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC5A5—malignant glioma	9.81e-05	0.000227	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KNG1—malignant glioma	9.81e-05	0.000227	CbGpPWpGaD
Acitretin—ALB—Metabolism—BCAN—malignant glioma	9.79e-05	0.000226	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTEN—malignant glioma	9.62e-05	0.000223	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IFNA2—malignant glioma	9.61e-05	0.000222	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.56e-05	0.000221	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NCOR1—malignant glioma	9.34e-05	0.000216	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.28e-05	0.000215	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	9.24e-05	0.000214	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.2e-05	0.000213	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SOD1—malignant glioma	9.11e-05	0.000211	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.1e-05	0.00021	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—RAF1—malignant glioma	9.04e-05	0.000209	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP9—malignant glioma	9.03e-05	0.000209	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	9.02e-05	0.000209	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—malignant glioma	8.91e-05	0.000206	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—malignant glioma	8.82e-05	0.000204	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—malignant glioma	8.52e-05	0.000197	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PTK2—malignant glioma	8.37e-05	0.000194	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	8.29e-05	0.000192	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—malignant glioma	8.2e-05	0.00019	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—malignant glioma	8.12e-05	0.000188	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—malignant glioma	8.11e-05	0.000188	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—malignant glioma	8.03e-05	0.000186	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.02e-05	0.000186	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—malignant glioma	8.02e-05	0.000186	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—malignant glioma	7.93e-05	0.000183	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GSTP1—malignant glioma	7.91e-05	0.000183	CbGpPWpGaD
Acitretin—ALB—Metabolism—IDH2—malignant glioma	7.89e-05	0.000183	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—malignant glioma	7.79e-05	0.00018	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CAT—malignant glioma	7.69e-05	0.000178	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—malignant glioma	7.64e-05	0.000177	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—malignant glioma	7.58e-05	0.000175	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.44e-05	0.000172	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2B6—malignant glioma	7.42e-05	0.000172	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—malignant glioma	7.32e-05	0.000169	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—malignant glioma	7.32e-05	0.000169	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—malignant glioma	7.3e-05	0.000169	CbGpPWpGaD
Acitretin—RXRA—Metabolism—NCOR1—malignant glioma	7.27e-05	0.000168	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—NOTCH1—malignant glioma	7.09e-05	0.000164	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	7.04e-05	0.000163	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PDGFB—malignant glioma	7.03e-05	0.000163	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PIK3CA—malignant glioma	6.96e-05	0.000161	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—malignant glioma	6.95e-05	0.000161	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—malignant glioma	6.9e-05	0.00016	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PIK3CA—malignant glioma	6.79e-05	0.000157	CbGpPWpGaD
Acitretin—ALB—Metabolism—IDH1—malignant glioma	6.79e-05	0.000157	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—malignant glioma	6.73e-05	0.000156	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PPARG—malignant glioma	6.7e-05	0.000155	CbGpPWpGaD
Acitretin—ALB—Hemostasis—CAV1—malignant glioma	6.66e-05	0.000154	CbGpPWpGaD
Acitretin—ALB—Metabolism—SPHK1—malignant glioma	6.57e-05	0.000152	CbGpPWpGaD
Acitretin—ALB—Metabolism—CYP2C18—malignant glioma	6.43e-05	0.000149	CbGpPWpGaD
Acitretin—ALB—Hemostasis—F2—malignant glioma	6.34e-05	0.000147	CbGpPWpGaD
Acitretin—ALB—Hemostasis—FN1—malignant glioma	6.34e-05	0.000147	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CG—malignant glioma	6.07e-05	0.00014	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.07e-05	0.00014	CbGpPWpGaD
Acitretin—ALB—Hemostasis—EGF—malignant glioma	6e-05	0.000139	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PTPN11—malignant glioma	5.96e-05	0.000138	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CAV1—malignant glioma	5.92e-05	0.000137	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—malignant glioma	5.91e-05	0.000137	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—malignant glioma	5.69e-05	0.000132	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.66e-05	0.000131	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT2—malignant glioma	5.55e-05	0.000128	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—malignant glioma	5.54e-05	0.000128	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.52e-05	0.000128	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	5.5e-05	0.000127	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—malignant glioma	5.4e-05	0.000125	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CG—malignant glioma	5.39e-05	0.000125	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CD—malignant glioma	5.33e-05	0.000123	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.33e-05	0.000123	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—malignant glioma	5.3e-05	0.000123	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPARG—malignant glioma	5.21e-05	0.00012	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTT1—malignant glioma	5.2e-05	0.00012	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—malignant glioma	5.18e-05	0.00012	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—malignant glioma	5.08e-05	0.000118	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—malignant glioma	5.08e-05	0.000118	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS1—malignant glioma	4.87e-05	0.000113	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.86e-05	0.000112	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RAF1—malignant glioma	4.76e-05	0.00011	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CD—malignant glioma	4.74e-05	0.00011	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CB—malignant glioma	4.65e-05	0.000108	CbGpPWpGaD
Acitretin—ALB—Metabolism—BCHE—malignant glioma	4.53e-05	0.000105	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	4.49e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC5A5—malignant glioma	4.48e-05	0.000104	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—malignant glioma	4.27e-05	9.88e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.23e-05	9.79e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.19e-05	9.71e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CB—malignant glioma	4.13e-05	9.56e-05	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	4.12e-05	9.54e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—malignant glioma	4.1e-05	9.48e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—malignant glioma	3.82e-05	8.83e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.66e-05	8.46e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—malignant glioma	3.63e-05	8.4e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—GSTP1—malignant glioma	3.61e-05	8.34e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTEN—malignant glioma	3.57e-05	8.26e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CAT—malignant glioma	3.51e-05	8.12e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—NCOR1—malignant glioma	3.31e-05	7.67e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—malignant glioma	3.09e-05	7.14e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PIK3CA—malignant glioma	2.83e-05	6.56e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—malignant glioma	2.74e-05	6.34e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—CAV1—malignant glioma	2.7e-05	6.25e-05	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—malignant glioma	2.65e-05	6.13e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.58e-05	5.97e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PIK3CA—malignant glioma	2.52e-05	5.83e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CG—malignant glioma	2.46e-05	5.69e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPARG—malignant glioma	2.37e-05	5.49e-05	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—malignant glioma	2.32e-05	5.36e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CD—malignant glioma	2.16e-05	5e-05	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—malignant glioma	2.06e-05	4.76e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CB—malignant glioma	1.89e-05	4.36e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—malignant glioma	1.87e-05	4.32e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTEN—malignant glioma	1.63e-05	3.77e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—PIK3CA—malignant glioma	1.15e-05	2.66e-05	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—malignant glioma	9.39e-06	2.17e-05	CbGpPWpGaD
